tvb-3567
·Code: TVB-3567
tvb-3567: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Sagimet Biosciences Inc. (SGMT) | Phase 1 |
Clinical Trials (1)
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TVB-3567 in Healthy Participants With or Without Acne and to Assess the Effect of Food in Healthy Participants
Frequently asked questions
Who is developing tvb-3567?
tvb-3567 is being developed by Sagimet Biosciences Inc..
How many clinical trials involve tvb-3567?
BioSniper tracks 1 clinical trial involving tvb-3567.
Get deeper analysis on tvb-3567
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis